$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Congressman Introduces Bill to Force FDA to Release Pfizer Documents Within 100 Days, Instead of 55 Years
02:38pm, Monday, 06'th Dec 2021 The Centre for Research on Globalization (CRG)
All Global Research articles can be read in 51 languages by activating the Translate Website drop down menu on the top banner of our home page (Desktop version). To receive Global Researchs Daily Newsletter (selected articles), click here . Visit The post Congressman Introduces Bill to Force FDA to Release Pfizer Documents Within 100 Days, Instead of 55 Years appeared first on Global Research .
STAT+: Pharmalittle: Covid-19 pills may take longer to reach poor countries; J&J Covid booster may be as beneficial as a third Pfizer shot
02:24pm, Monday, 06'th Dec 2021 STAT News
People who received the Pfizer-BioNTech Covid vaccines may get as much benefit from a J&J booster shot as a Pfizer one.
South Africas Biovac to start making Pfizer-BioNTech COVID-19 vaccine in early 2022 exec
01:50pm, Monday, 06'th Dec 2021 National Post
KIGALI South Africas Biovac Institute will start making Pfizer-BioNTechs COVID-19 vaccine early next year after receiving the drug substance from facilities in Europe, a Pfizer executive said on Monday. That earlier than the forecast start at around the second half of 2022 given by Cape Town-based Biovacs chief executive in July when the partnership []
Vit Nam 9th globally for vaccinations, received 150mln vaccine doses
01:36pm, Monday, 06'th Dec 2021 Vit Nam News
Vit Nam has received over 150 million doses of COVID-19 vaccines, with Sinopharm, AstraZeneca and Pfizer accounting for the majority.
Johnson & Johnson Booster COVID-19 Shot Shows Encouraging Action After Pfizer/BioNTech Jab
01:09pm, Monday, 06'th Dec 2021 Benzinga
Johnson & Johnson (NYSE: JNJ ) announced preliminary results from an independent study, including a subset of the Janssen-sponsored COV2008 study participants. The article describing these results has been posted on medRxiv . The study showed a booster shot of the Johnson & Johnson COVID-19 vaccine, administered six months after a two-dose primary regimen of Pfizer Inc (NYSE: PFE ) / BioNTech SE (NASDAQ: BNRX) BNT162b2 (Comirnaty) increased antibody Full story available on Benzinga.com
Mass vaccination again this week in Dubrovnik - special service for foreigners
12:40pm, Monday, 06'th Dec 2021 The Dubrovnik Times
A mass vaccination will be organized for all interested Croatian citizens who want to receive the first and booster dose on Wednesday and Thursday (December 8 and 9, 2021) from 8:00 am to midday. The vaccination point in the week ahead will be organized in the Sports Hall in Gospino polje. Please note that the booster dose can be given to all people who received the second dose of vaccine 6 months ago and the vaccines on offer are Pfizer, Moderna and AstaZeneca, or 2 months since receiving one dose of Johnson & Johnson. There will be no vaccination of foreigners on these days, and all foreign citizens interested in vaccination can organize their vaccination outside the checkpoint via e-mail: [email protected] . (adsbygoogle = window.adsbygoogle || []).push({});
Researchers reveal which vaccine is more effective: Pfizer or Moderna
12:30pm, Monday, 06'th Dec 2021 The Olive Press
A STUDY involving almost half a million people has been carried out to determine which of the two most popular vaccines are more effective against the Covid-19 virus. The Pfizer-BionTech and Moderna comparison was done using medical histories of 439,684 American citizens that had received one jab or the other. Although both were very effective []
Global Heparin Market to Touch a Revenue of USD 7938.6 Million by 2030; Rising Incidences of CVDs to Create Opportunities for Market Growth
12:30pm, Monday, 06'th Dec 2021 Intrado Digital Media
Key Companies Covered in the Heparin Market Research Report Are GlaxoSmithKline plc, Pfizer Inc., Aspen Holdings, Baxter International Inc., Fresenius Kabi AG, Amphastar Pharmaceuticals, Inc., Mylan N.V., Sanofi, LEO Pharma A/S, B.Braun Melsungen AG, and other key market players. Key Companies Covered in the Heparin Market Research Report Are GlaxoSmithKline plc, Pfizer Inc., Aspen Holdings, Baxter International Inc., Fresenius Kabi AG, Amphastar Pharmaceuticals, Inc., Mylan N.V., Sanofi, LEO Pharma A/S, B.Braun Melsungen AG, and other key market players.
Global Monoclonal Antibody Treatment Market Growth Analysis, Latest Trends and Forecast till 2027| Pfizer, Bayer, Sanofi, Merck, GlaxoSmithKline
12:26pm, Monday, 06'th Dec 2021 OpenPR
The global Monoclonal Antibody Treatment market size is projected a CAGR of 13.3% during 2021-2027. Increased cancer prevalence, increased demand for cost-effective biosimilar monoclonal antibodies, high demand for biologics, and increased genomics R&D activities, as well as the introduction of
Neurodegenerative Disease Market Recent Trends, Future Growth Analysis Forecasts 2027| Novartis, Pfizer, Merck Serono, Biogen Idec
12:23pm, Monday, 06'th Dec 2021 OpenPR
The global Neurodegenerative Disease market size is projected a CAGR of 3.4% during 2021-2027. The rising frequency of neurological illnesses, more public awareness, and a robust product pipeline for neurodegenerative disease treatment are all driving the growth of the neurodegenerative
Pfizer/BioNTech''s COVID-19 Shot Receives Emergency Use Nod In Australia For Kids Aged 5-11 Years
10:23am, Monday, 06'th Dec 2021 Benzinga
Australia''s Therapeutics Goods Administration provisionally approved Pfizer Inc (NYSE: PFE ) / BioNTech SE''s (NASDAQ: BNTX ) COVID-19 vaccine for children between 5 and 11 years. The health minister said that the rollout could begin from January 10, 2022. The FDA approved Pfizer/BioNTech COVID-19 vaccine for emergency use in kids aged 5-11 years in October . "The authority has … Full story available on Benzinga.com
Vaccine registration for kids under 12 opens Wednesday
10:18am, Monday, 06'th Dec 2021 Portfolio Hungary
Pfizer will be the only vaccine used
Babies hospitalized after getting Covid-19 vaccine
10:12am, Monday, 06'th Dec 2021 Big News Network
Two Brazilian babies have ended up in hospital after a nurse confused the vials and mistakenly injected them with Pfizer coronavirus vaccine instead of their intended infants? jabs. The shocking blunder was first reported by the media and officially confirmed on Sunday by local authorities in the Sorocaba municipality of Brazil''s Sao Paulo state. A two-month-old girl and a four-month-old bo
Australia approves Pfizer''s COVID-19 vaccine for children aged 5-11 years
09:47am, Monday, 06'th Dec 2021 Seeking AlphaAFL great on ''scariest'' two weeks of his life in ICU with Covid after ''bad reaction'' to Pfizer jab
09:19am, Monday, 06'th Dec 2021 Daily Mail Online
Paul Dimattina spent six days in ICU and four days in a ward at The Alfred in Melbourne after suddenly becoming very ill. Despite having three vaccine jabs, he caught Covid as he is immunocompromised.
Sign In
Buy PFE